200 related articles for article (PubMed ID: 15195247)
1. Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike protein.
Yao YX; Ren J; Heinen P; Zambon M; Jones IM
J Infect Dis; 2004 Jul; 190(1):91-8. PubMed ID: 15195247
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
[TBL] [Abstract][Full Text] [Related]
3. Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus.
Lu L; Manopo I; Leung BP; Chng HH; Ling AE; Chee LL; Ooi EE; Chan SW; Kwang J
J Clin Microbiol; 2004 Apr; 42(4):1570-6. PubMed ID: 15071006
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
[TBL] [Abstract][Full Text] [Related]
5. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.
He Q; Manopo I; Lu L; Leung BP; Chng HH; Ling AE; Chee LL; Chan SW; Ooi EE; Sin YL; Ang B; Kwang J
Clin Diagn Lab Immunol; 2005 Feb; 12(2):321-8. PubMed ID: 15699428
[TBL] [Abstract][Full Text] [Related]
6. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
[TBL] [Abstract][Full Text] [Related]
7. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; Hsiang CY
Biochem Biophys Res Commun; 2004 Jan; 313(4):938-47. PubMed ID: 14706633
[TBL] [Abstract][Full Text] [Related]
8. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV.
Lokugamage KG; Yoshikawa-Iwata N; Ito N; Watts DM; Wyde PR; Wang N; Newman P; Kent Tseng CT; Peters CJ; Makino S
Vaccine; 2008 Feb; 26(6):797-808. PubMed ID: 18191004
[TBL] [Abstract][Full Text] [Related]
9. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
He Y; Lu H; Siddiqui P; Zhou Y; Jiang S
J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718
[TBL] [Abstract][Full Text] [Related]
10. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
[TBL] [Abstract][Full Text] [Related]
11. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.
Maache M; Komurian-Pradel F; Rajoharison A; Perret M; Berland JL; Pouzol S; Bagnaud A; Duverger B; Xu J; Osuna A; Paranhos-Baccalà G
Clin Vaccine Immunol; 2006 Mar; 13(3):409-14. PubMed ID: 16522785
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV.
Manopo I; Lu L; He Q; Chee LL; Chan SW; Kwang J
J Immunol Methods; 2005 Jan; 296(1-2):37-44. PubMed ID: 15680149
[TBL] [Abstract][Full Text] [Related]
13. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
[TBL] [Abstract][Full Text] [Related]
14. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
Miyoshi-Akiyama T; Ishida I; Fukushi M; Yamaguchi K; Matsuoka Y; Ishihara T; Tsukahara M; Hatakeyama S; Itoh N; Morisawa A; Yoshinaka Y; Yamamoto N; Lianfeng Z; Chuan Q; Kirikae T; Sasazuki T
J Infect Dis; 2011 Jun; 203(11):1574-81. PubMed ID: 21592986
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.
Li J; Ulitzky L; Silberstein E; Taylor DR; Viscidi R
Viral Immunol; 2013 Apr; 26(2):126-32. PubMed ID: 23573979
[TBL] [Abstract][Full Text] [Related]
16. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.
He Y; Zhou Y; Wu H; Luo B; Chen J; Li W; Jiang S
J Immunol; 2004 Sep; 173(6):4050-7. PubMed ID: 15356154
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein.
Bisht H; Roberts A; Vogel L; Subbarao K; Moss B
Virology; 2005 Apr; 334(2):160-5. PubMed ID: 15780866
[TBL] [Abstract][Full Text] [Related]
18. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV.
Fukushi S; Mizutani T; Saijo M; Kurane I; Taguchi F; Tashiro M; Morikawa S
J Med Virol; 2006 Dec; 78(12):1509-12. PubMed ID: 17063504
[TBL] [Abstract][Full Text] [Related]
20. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
